| |
| |
|
| Insider
Information: |
Hawkins Richard J |
| Relationship: |
Chief Executive Office... |
| City: |
San Mateo |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
793,237 |
|
|
Indirect Shares
|
4,469 |
|
|
| Direct
Value |
$1,839,869 |
|
|
|
Indirect Value
|
$10,055 |
|
|
| Total
Shares |
797,706 |
|
|
| Total
Value |
$1,849,924 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
5
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
5
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-5.0
|
0.0
|
| Percentage
Gain/Loss : |
 -51.2%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Plus Therapeutics Inc |
PSTV |
|
2024-05-08 |
4,903 |
2009-04-30 |
0 |
Premium* |
|
|
Sciclone Pharmaceuticals Inc |
SCLN |
Director |
2017-10-13 |
0 |
2014-09-29 |
0 |
Premium* |
|
|
Savara Inc |
SVRA |
Director |
2023-12-14 |
35,241 |
2019-05-14 |
0 |
Premium* |
|
|
Lumos Pharma Inc |
LUMO |
Chief Executive Office... |
2024-04-01 |
753,093 |
2024-04-01 |
4,469 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
47 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PSTV |
Plus Therapeutics Inc |
Director |
– • – |
2009-04-30 |
4 |
A |
$0.00 |
$0 |
D/D |
3,142 |
3,142 |
0 |
- |
|
| PSTV |
Plus Therapeutics Inc |
Director |
– • – |
2010-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
943 |
4,085 |
0 |
- |
|
| PSTV |
Plus Therapeutics Inc |
Director |
– • – |
2011-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
10,085 |
0 |
- |
|
| PSTV |
Plus Therapeutics Inc |
Director |
– • – |
2012-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
20,085 |
0 |
- |
|
| PSTV |
Plus Therapeutics Inc |
Director |
– • – |
2013-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
6,100 |
6,100 |
0 |
- |
|
| PSTV |
Plus Therapeutics Inc |
Director |
– • – |
2014-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,550 |
10,550 |
0 |
- |
|
| PSTV |
Plus Therapeutics Inc |
Director |
– • – |
2014-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
5,191 |
15,741 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
Director |
– • – |
2014-09-29 |
4 |
OE |
$4.55 |
$227,500 |
D/D |
50,000 |
50,000 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
Director |
– • – |
2014-12-10 |
4 |
S |
$8.79 |
$130,610 |
D/D |
(14,851) |
35,149 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
Director |
– • – |
2014-12-11 |
4 |
S |
$8.82 |
$6,527 |
D/D |
(740) |
34,409 |
0 |
- |
|
| PSTV |
Plus Therapeutics Inc |
Director |
– • – |
2015-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
34,228 |
34,228 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
Director |
– • – |
2015-05-14 |
4 |
S |
$9.16 |
$171,571 |
D/D |
(18,727) |
15,682 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
Director |
– • – |
2015-05-21 |
4 |
S |
$9.71 |
$35,914 |
D/D |
(3,700) |
11,982 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
Director |
– • – |
2015-05-26 |
4 |
S |
$9.44 |
$113,145 |
D/D |
(11,982) |
0 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
Director |
– • – |
2015-05-29 |
4 |
OE |
$3.27 |
$34,106 |
D/D |
10,430 |
10,430 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
Director |
– • – |
2015-05-29 |
4 |
S |
$9.32 |
$97,182 |
D/D |
(10,430) |
0 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
Director |
– • – |
2015-06-01 |
4 |
S |
$9.27 |
$42,371 |
D/D |
(4,570) |
0 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
Director |
– • – |
2015-06-01 |
4 |
OE |
$3.27 |
$14,944 |
D/D |
4,570 |
4,570 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
Director |
– • – |
2016-05-05 |
4 |
OE |
$2.46 |
$73,800 |
D/D |
30,000 |
30,000 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
Director |
– • – |
2016-05-05 |
4 |
D |
$13.09 |
$73,788 |
D/D |
(5,637) |
24,363 |
0 |
- |
|
| PSTV |
Plus Therapeutics Inc |
Director |
– • – |
2016-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,356 |
8,435 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
Director |
– • – |
2016-08-12 |
4 |
OE |
$1.75 |
$288,000 |
D/D |
120,000 |
54,363 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
Director |
– • – |
2016-08-12 |
4 |
S |
$10.37 |
$1,244,724 |
D/D |
(120,000) |
24,363 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
Director |
– • – |
2017-10-13 |
4 |
D |
$11.18 |
$272,378 |
D/D |
(24,363) |
0 |
0 |
- |
|
| SVRA |
Savara Inc |
Director |
– • – |
2019-05-14 |
4 |
OE |
$0.52 |
$13,013 |
D/D |
25,000 |
25,000 |
0 |
- |
|
47 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
